Abstract
This report analyzes the worldwide markets for Hepatitis C Virus And
Therapeutics in US$ Millions. Annual forecasts are provided for each region
for the period of 2006 through 2015. The report profiles 123 companies
including many key and niche players such as Abbott Diagnostics, Achillion
Pharmaceuticals, Inc., Anadys Pharmaceuticals, Inc., Boehringer Ingelheim
GmbH, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline
plc, Hayashibara Biochemical Labs, Inc., HemispheRx Biopharma, Inc., Human
Genome Sciences, Idenix Pharmaceuticals, Inc., Innogenetics NV, InterMune,
Inc., Intarcia Therapeutics, Inc., Medivir AB, Merck & Co., Inc., Novartis AG,
Chiron Corporation, Pfizer, Inc., Schering-Plough Corporation, Tibotec
Pharmaceuticals Ltd., Tripep AB, Toray Industries, Inc., Valeant
Pharmaceuticals International, and Vertex Pharmaceuticals, Inc. Market data
and analytics are derived from primary and secondary research. Company
profiles are mostly extracted from URL research and reported select online
sources.
| 
View Cart
